Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared on LinkedIn:
“Does metastatic breast cancer always require chemotherapy first?
For many patients with hormone receptor-positive, HER2-negative disease, treatment begins with hormone therapy, usually combined with a targeted medicine.
In the latest How Doctors Decide episode, I explain why this approach plays such an important role – and how doctors think through the first treatment decision.
Share this with someone who wants to better understand their treatment options.
What would you want your oncology team to explain about choosing a first treatment?”
You can also read:
